Nath Bio-Genes (India) Limited has informed the Exchange regarding Outcome of Board Meeting held on April 29, 2025.
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nath Bio-Genes (India) Limited has submitted a filing to the NSE disclosing the outcome of its Board of Directors meeting held on April 29, 2025. The company is informing the stock exchange about decisions taken at this meeting, as required under SEBI's listing rules. The actual decisions (such as dividend declaration, financial results, fundraising, or other corporate actions) are not detailed in the headline and would normally be found in the attached board resolution or detailed filing. This is a routine regulatory compliance disclosure submitted shortly after the board meeting concluded.
No direct impact on the stock can be assessed from this headline alone, as the specific board decisions are not visible. Investors should look at the full filing or attached board resolution to understand whether any material action (dividend, results, expansion, etc.) was taken.